First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors.

Autor: Guo, Ye1 (AUTHOR), Wang, Zishu2 (AUTHOR), Zhou, Huan2 (AUTHOR), Pan, Hongming3 (AUTHOR), Han, Weidong3 (AUTHOR), Deng, Yanhong4 (AUTHOR), Li, Qun1 (AUTHOR), Xue, Junli1 (AUTHOR), Ge, Xiaoxiao1 (AUTHOR), Wang, Shuang5 (AUTHOR), Wang, Jing6 (AUTHOR), Zhang, Yue5 (AUTHOR), Zhao, Congqiao5 (AUTHOR), Zhu, Huaqiang5 (AUTHOR), Wang, Yu5 (AUTHOR), Shen, Haige5 (AUTHOR), Liu, Dong6 (AUTHOR), Li, Jin1 (AUTHOR) lijin@csco.org.cn
Zdroj: BMC Cancer. 4/10/2024, Vol. 24 Issue 1, p1-13. 13p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje